Xylem Inc. $XYL Shares Sold by Keybank National Association OH

Keybank National Association OH lessened its holdings in shares of Xylem Inc. (NYSE:XYL) by 17.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 127,044 shares of the industrial products company’s stock after selling 26,282 shares during the quarter. Keybank National Association OH’s holdings in Xylem were worth $18,739,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. AQR Capital Management LLC boosted its position in Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after acquiring an additional 3,900 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after purchasing an additional 132 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock worth $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Xylem by 7.1% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,094 shares of the industrial products company’s stock valued at $4,669,000 after purchasing an additional 2,390 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in Xylem by 25.8% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 4,264 shares of the industrial products company’s stock worth $552,000 after buying an additional 875 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is currently owned by company insiders.

Xylem Price Performance

Shares of XYL opened at $137.89 on Friday. The company has a market cap of $33.57 billion, a P/E ratio of 35.45, a PEG ratio of 1.96 and a beta of 1.17. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. The firm’s 50 day moving average price is $139.60 and its 200 day moving average price is $141.82.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s payout ratio is presently 41.13%.

Analyst Ratings Changes

Several research firms have recently commented on XYL. Barclays reduced their price target on Xylem from $172.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, January 7th. Argus set a $170.00 target price on shares of Xylem in a research note on Wednesday, October 29th. Mizuho decreased their target price on shares of Xylem from $160.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, January 5th. Stifel Nicolaus raised their price target on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Finally, Royal Bank Of Canada upped their price objective on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $165.80.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.